Retrieve available abstracts of 8 articles: HTML format
Single Articles
September 2025
DI LORENZO G, Verde A, Scafuri L, Baio R, et al Development and validation of the PREVES-HOR Questionnaire: a patient-reported
measure of hormone-therapy-related quality of life in prostate-cancer patients
undergoing androgen-deprivation therapy.
Oncology. 2025 Sep 29:1-29. doi: 10.1159/000548317. PubMedAbstract available
July 2025
TAPIA-SALAS IA, Dorantes-Heredia R, Flores-Marinelarena RR, Moreno-Lopez R, et al Evaluation of HER2 expression in prostate cancer among Mexican patients.
Oncology. 2025 Jul 14:1-16. doi: 10.1159/000547372. PubMedAbstract available
March 2025
CHEN J, Fu S, Yu J, Tang Q, et al Modified Glasgow prognostic score as a marker for predicting outcomes in patients
with either bladder and prostate cancer : A systematic review and meta-analysis.
Oncology. 2025 Mar 28:1-20. doi: 10.1159/000545001. PubMedAbstract available
January 2025
GUI Q, Wang X, Wu D, Guo Y, et al Constructing and Validating Models for Predicting Gleason Grade Group Upgrading
Following Radical Prostatectomy in Localized Prostate Cancer: A Comparison
between Machine Learning Algorithms and Conventional Logistic Regression.
Oncology. 2025 Jan 24:1-15. doi: 10.1159/000543492. PubMedAbstract available
October 2024
NOVYSEDLAK R, Guney M, Al Khouri M, Bartolini R, et al The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.
Oncology. 2024 Oct 9:1-37. doi: 10.1159/000541881. PubMedAbstract available
August 2024
MASUDA R, Noguchi Y, Aizawa H, Yoshizawa S, et al Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor
Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan.
Oncology. 2024 Aug 14:1-9. doi: 10.1159/000540864. PubMedAbstract available
January 2024
SCHAULIN MS, Delouya G, Zwahlen D, Taussky D, et al Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
Oncology. 2024;102:283-290. PubMedAbstract available
December 2023
JI WT, Jin XF, Wang Y The rate of clinically significant prostate cancer on repeat biopsy after a
diagnosis of atypical small acinar proliferation: A systematic review and
meta-analysis.
Oncology. 2023 Dec 7. doi: 10.1159/000535123. PubMedAbstract available